pre-miRNA Information | |
---|---|
pre-miRNA | hsa-let-7a-1 |
Genomic Coordinates | chr9: 94175957 - 94176036 |
Synonyms | LET7A1, MIRNLET7A1, let-7a-1, MIRLET7A1 |
Description | Homo sapiens let-7a-1 stem-loop |
Comment | let-7a-3p cloned in has a 1 nt 3' extension (U), which is incompatible with the genome sequence. |
RNA Secondary Structure | |
Associated Diseases | |
pre-miRNA | hsa-let-7a-3 |
Genomic Coordinates | chr22: 46112749 - 46112822 |
Synonyms | LET7A3, MIRNLET7A3, let-7a-3, MIRLET7A3 |
Description | Homo sapiens let-7a-3 stem-loop |
Comment | let-7a-3p cloned in has a 1 nt 3' extension (U), which is incompatible with the genome sequence. |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-let-7a-3p | |||||||||||||||||||||||||||||||||||||||
Sequence | 57| CUAUACAAUCUACUGUCUUUC |77 | |||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||||||||
Experiments | Cloned | |||||||||||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
|||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TOR1AIP2 | ||||||||||||||||||||
Synonyms | IFRG15, LULL1, NET9 | ||||||||||||||||||||
Description | torsin 1A interacting protein 2 | ||||||||||||||||||||
Transcript | NM_022347 | ||||||||||||||||||||
Other Transcripts | NM_145034 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TOR1AIP2 | |||||||||||||||||||||
3'UTR of TOR1AIP2 (miRNA target sites are highlighted) |
>TOR1AIP2|NM_022347|3'UTR 1 CTTCTATAATAGTCAAAATTGTCAAGTCTAGAGGCTTTTGTGTAGGTAGCCCAAGGAAGATGGAAAAATAATTCATTTCT 81 AAGTCTGACCCAGATTGTCACTACTTTGGGAACTGCTTAAATTGTTGGATCTGCTTCCGTGGCCTATACATATTTTATTC 161 ACATGAATTTAGTTAGTATTCCAGCCAGCCTGTTCATCTAGACTGAGGCTAATCTGTTCATCTAGACTGAGGCTAATCCG 241 TATTTCCTATAAACTGTTTTGGAACTAACTTACCACTCCTAAAAAAATTTCTGCAACCTAATGAGTGTCATATGACAAAG 321 TAGTCCTAGAGGGGAAGTCCTATACTGTGTGCTTCATAGTGGTATTTCTAATGATAACTTTTGTGGGAAAGCAGCCTCGT 401 TATAGCTGGATCCTAGATTAGTCCAGTGAATTTTAATAAGAAATTACACTGTTGTAAACTCACCTCTTATGCATTGGTCA 481 GTGATGAGATATATATATAAATAGATAGATAGATAAAATTTGCTCTTATATAGCCATTTATTCATCATTGGCCCTGTTTG 561 GCCCATCCTCAGTGTGGCTGTGAGATTATTGATAACTGGTCACTGTCAGATAAATCACATTCTATTAGGAAACACCTATA 641 TAGGTTATGCAGAAACATGCAGAAATGCCACCTGTCCATACTTACGTGGCTTTACATAAACAAAAGACTGTCTTGTCTTT 721 GTGGTGACTGAATTTACAACGTCCTCCCCTGGAAATGGAAAAGTACCTATCAGGAGATGTATGACAAAAGAAATTATCAA 801 GCCTGACTTCATATATATTATGAACAGTCTAGAGGAAGCATCTTTCTTAGAACTAAGGAGGTCTGCTGAACATTGGCCAC 881 ATTCTGGACTTTCATGAAAATCATGGACCCAGAGTTGGGGTTAAGCCACTTAGAAAAAGCTGTTGAAAACATCTCAAAGG 961 CCACTGAACAATTTTTAAATTACACTTAACATGCCAGGTATCTAGGTATCTAGTGCTTTTAGCAATATTATCAATATTAT 1041 CAAGGTCCCAGCTTCTTTGTGTCCTTCCCCCTTGCGATCCTCTTTTTTTTTTTTTTTTTTTTTGCTTTTTAAAAAATAGT 1121 GACAGAGTCTTGCTGTATGACCCAGGCTGGTCTCCAACTCCTAGGCTCAAGCCATCCTCCCACCTCGGTCTCCCAAGGTG 1201 CTGGGATTACAGGCGTGAGCCACCCTACCCGGCCTAGGATCCATGTTTGCTTTTTATCGTTAGGTTTTTTTTTCTCAATG 1281 AGTACAATATGACTTCTTGTTGTAACAGACATTTTAATCCCTAGGAAAGGCTGGAAGTAGAGAGCAAAAGGCTTTCTTTC 1361 AAGTCAGTGTTTTATTTGGGAATCAAGTCTTTCCCAAAAATCCCTAGCAAATTTCTTCTTACATCTCATTAGAAAGTACC 1441 AGTTTACAAGGGAGCCTGGGAAACCTTGGCAAAGGGGAATAGGGTTAGCATTGCCTGGGTAGGCCACATTGCCTCCATTG 1521 AAGAAATCAGGGCTTTTTTTTTTTTTTTTTTTTTTTTGAGACAGAGTCTCACTCTGTCGCCCAGGCTGGAGTGCAGTGGC 1601 AGTCTTGGTTCACTGCAACCTCTGCCTTCCGGGTTCAAGCAATTCTCCTGCCTCAGCCTCCCGAGTAGCTGGGACTACAG 1681 GTGTGCGCCACCACACTTGGCTAATTTTTGTATTTTTAGTAGAGATGGGGTTTCACCATTGTTGGCCAGGATGGTCTTGA 1761 TCTCTTGATCTCATGATCCACCCGCCTTGGCCTCCCAAAGTGCTGGGATTACAGGCATGAGCCACTGTGCCCAGCCCTTT 1841 TTTTTTTTTTTTTTTGACGGAGTCTCGCTCTCTTGCCCAGGATGGAGTGTAGTGGCACGATCTCGGCTTACTGTAACCTC 1921 CACCTCCTAGGTTCAAGCAATTCTCCTGCCTCAGCCTCCTGAGTAGTGGGGATTACAGGTGCCCGCCACCATGTCTGGCT 2001 AATTTTTGTGTTTTTAGTAGAGACGGGGTTTCACCATGTTGGCCAGGCTGGTCTTGAACTCCTGACCTCAGATGATCCAC 2081 CTGCCCTGACCTCCGACAGTGCTGGGATTACAGGCATAGCCACCGTGCCTGACCAGGGCTCTTTTAGCAAGGAAAACGTG 2161 AGGAATGAATGGCTGTTGGTGTGCAACAAATCATACTTGCTACATGTTGTGAAACCTGAAGTTATTTGTTAGTCTGTATG 2241 AAGAATGTACCCCAGAGATGCACCCTGTATCTGCCTTATGTCTCTTACAATGGAGGTTCTCTCCTGTTATATTGCTGAAT 2321 AAACTATGTGAACTGCTAAATTGACTGAAGACTAGTTAGTTTATCACTAACTCTTTAATGAAGAATTTCACTATCCTACA 2401 ACTCCTCCTAAAAAGTGAAAATTTACTTTGAGAGAGTGCTTTCGAGAATAGTATTATGATCAGTATTATTGCCCCTAAAT 2481 TTTTTAATTATTAGAGAATGCTTATGTTACAAGGACATATACTAAGAAACATTCTACAAATGTGAAAATTTAAATATCAG 2561 CAAAATAGAGAAAAGGTTTTTGTTTTTGTTTTAGTCAATATCTCCATTAAATAGTAAGATCAGATTAAAAGGATTTATAT 2641 CATTGATTTCTCAAATCAATACCTAAGCAGTACCTGTGAGAGCTTGTTTAAAAATGGAGATTTCTTGGTCTGCTTTAGAA 2721 ATTTTGATTCCTCAGGTTGCTTGTAGGGCCCAGGAATCTGCATATTATAAATAACACCTCATGCCGGGTGCCATGGCATG 2801 TACCTGTTACCACAGCTACTTCAGAGGTTGAGGCAGCAGGATCACTTGAGCCCAGGAGTTCAAGACCAGCCTGGGCAAGA 2881 TAGTCAGACCACTGTCTCTTTCAAGAAAAAAAAACAACATAAAAGATATAAATAGTACCTTTGGAGATTCTGATGCAGGT 2961 GCTCTCTAGACCATACTTTGAGAAATGCTGTAGTAATATGTCCATAGTGTTTACTTATCTGGCTTAAAAGGATGGGAGCA 3041 GAATACTCATAGTACTGCAAGATAGTACCATTTATTTGGTAATACTGGCTATGTAAAAAGAGATTTCATGTCAGACTGAA 3121 GATCACTGTTAATAATTTAGGTCATAACTCAGCCACATTTTTCTCATTAATTAAACTAATCAGGAATGTTTCAGTCTTCT 3201 TCACAAACAGTTTTGTTCAGTGTCATTATAAACTATGTGAATATATGGGCAAGAAAAATGAATCAAAAATATTAATTTTA 3281 ATATTAAGAGGGTTACTTTGCCTTCAAACATCACATACCTGTTATATGATAAGCTGTCAGAAATCAACATCATGTAGTAG 3361 AGCTCATAAAATTGAGCAAAGGAGAAAATTGAGGAAGCCTTTGAACAAAGCTTTTCACCTTAGGTCTTTCTAGTATGTCT 3441 TCATATGGCTTAAAATATTGCAGGTTATTCTAGAATACTCCATAGTTGATATGAATAATGAATTTTATTAAAATATAAAT 3521 GCTGTGTTGGTAAAATTAATTGTAATGACAAATGATCTGGAGGGTTATCCAGTGTTTTAAATAGTGTGAGCTACACTCGT 3601 CTCTATTTTTATAGTGTGGAAGAGTTGGTAATATTGCTTATATGTTATGGTAGCATTTCTAAAATGACCATTATAACTAC 3681 TCCCTGTTATTTTATGGCAGTCCAGGGAGTGAAAAGGTTAATGGAAACATGCAAGGGCAGACCGGAAAGAAAATACATCC 3761 ACCAAAGAGGTGGCTGTTGGGGGATATGAGTGAGTGAGGTAAGATTCATCTCTGAGTTACAGGTGAAGGAAGCCCAGGCA 3841 AACAGGAAGGCAGAAATGAGTCCATGGCATCCAAAGAATATGTGGCAGTCCACATGTCATAGCTGTCTGTAAAAGTGAGA 3921 TGAGCCGCAGCCCGTTCATCTCTCCAGTCTCCCTGGCAACCCTGAGTCTCCATGGAATTTTGGGGACACAGCTTGAAAAT 4001 TGCTTTTTATAGAGGCAAAATAATGGCCTTGCAGCCAGCTGGGTTTCTATTCTAATTCTGATACTATTAAATGACCTTAG 4081 GCATTTTAACCTCTCTGTATCTAGTTTCTTCATCTGTGAAAAAGGTTGTGTAATAATACCTACCTCATACTGTTGTGAGG 4161 TTTAAGTGCAATAACATATACCAAACATATGGCACATACTAAATCTTTAGGATGAGGAAAGATGTAGGGCAAGAAAGCAA 4241 AAGCAGAAGTTAGAACTGGGGAATAAGGTAGAGTCTTACTTGTTTTGTTTTGTTTTTTTGAGACAGAGTCTCGTTCTGTC 4321 ACCTAGGCTGGAGTGCAGTGGCGCCATCATGGCTCACTGCAGCCTTGACCTTCTGGGCTCAAGTGATCCTCCCACTTCAG 4401 CCCCCTAAGTAGCTGTGACTACAGGCTTGCACCACCATGCCCAGCTAATTTTTTTATTTTTGTAGAGATGGAGTATCGCC 4481 ATGTTGCCCAAGCTGGTCTTGAGCTCCTGGCCTCAAGCGATCCTCTCACCTGGGCCTCCCAAAGTGCTGGGATTATAGGC 4561 ATGAGCCGCCGTGTCCACCGAGTCTTAGTTTTAGAACTAAGCCAATTGTTTGAACTGATGGCTGAATTATTATAAACTTA 4641 TTGGCTGGTGGCTCACTGTAATTCCAGCACTTTGGGAGGCTGAGGCAGGAGGATGGCTTGAGCCCAGGAGTTCAAAACAA 4721 GCCTGAGCAACATAGTGAGACCCCCAACTCTACAAAAAAGTTTTAAAAAGAAAAAAATTAGCTGGATGTGGTGGTATGTG 4801 CCTGTAGTCCCAGCTACTCAGGAGGCTGAGGTGGGAGGATCACTTGAGCCTCAGTGAGCTATGAGCTTGAGGCTGCAGTG 4881 AGCTATGATGGTACTACTGCCCTCCAGCCTGGGCAACAGAGTAAGGCCCTTTATCTAAAAACAAAAACAAAAAACTTCTT 4961 AAATCTCTCCTGATGAAGGACAGGATTGGTTTGGGGATGAGGTTGAGCCTGTAGTATAAGTCAGATGGTCTTGGGTGTAA 5041 AGATTAAAAGGCCTGGAGGGATGGATGACCGAAGGCAGATTTTTGTCACAATGTTTAGGCCCATTTTATAATCTTAATTA 5121 TGGTAGATATAATTGCTGTATGACTTTTATCACCTGAGACTTTCCACAACACTGAAATAAACAAATTCCTGAAGTGGTAG 5201 TTCCCTGAAAAGGAAAAAGAAGAAATAGAGAAAAGTTGAAGGATATGTACAAATTCACTCAGGTCATATGTACTGGAGTC 5281 ACAATTCAAACCTAGATGTAAGTTTTCCAGAGTCAGGGTGCTTGTGGTATGCTTAATACAAGCTTTTAAAAGTGTCATGG 5361 TTAGGTCCCACAGCTAGACTACCTGAGTTCAAATCCTAACTGCCCTCAGTAGTCACGTGTTCTTGGGTAACGTTCTTAAC 5441 TTTTCTGTATCTCAGTTTCCTCATCTCTAAAATAGTAGGAATATTAATAGTCTACACCTCATAAGATTGTTGTGAAGATT 5521 AAACGAGTTAATAAAGTGCTGTGAATGATGCCTGGCACAAAGAAGGCACTCAATAAATAGTAGTTCTTATAGTTGTTGTA 5601 TATGCTTTATTTGTTACTCGTTTTCATAGCAGGATTGTAACTACTTGTTTCAGGGCCAAGATACCAGTTTCTTTTTATCC 5681 CTAGAGCCTAAAATGGCATCATTCACTAAAATAAAATTGTGTTTAAAAATAAAGATATATACTTAATTCTACCCCAACTG 5761 TCATACATTTGTCATGATGGCATTTATATCTAAACTACCATCCTGGAATGGCTGATTCTTTTGTGCTCTTCTTGGCTGCT 5841 AAACTTCTAATTTCCTTCTCCATTTAAAAAATGGTCTTAGTACTTCCTGATACCTACCCTGCCTCCCCTCCCCAGGTTTT 5921 CCCCAGGTCACCATCCCTTCCCCTCTTTTTCACTGGTCGCCATGGCAATGCTAGCAATTTGCAGGATGGAGTGGAGGATG 6001 GGTAAGGTCCTTTTGCTCTCCCAGCTCTGATTTTGTTCTCACAGGCAGCTTTTCCGTGTCCTGTCTCTTCTCAGCTGGTT 6081 GTGACAAAATGTCTAGGAGGCTATGGTGGAAGCGTACTCCGTAATGTAAGGTCATTGCATGTAGGCTGAAAGAGTTTCCA 6161 TTATAGGTCTTTCCTTTTGATACTTAATTTTTTTTTACAGAGACTGATTTATTTTATTACTCATTTAAAAAGGCAGTAAC 6241 TACATCAAACATACAGAAAAGTGCAGAGAATAATATAGTAAGACCTTTGCCCAGATCTAAAATATATGAACATTTTATCC 6321 CATTTACCTCAGATGTTTTTATTTTTTTAAGGAAACTTTATGTGTACAGTTGACACCCTCTCTTATTCCTTGCAGAAGCA 6401 AGCACTAAATGGAAGTTGATATGTATCCTTTCCATTTATGTATTTATGTTTTGTTATAAATTTATATATGTTAATAATGC 6481 TGTACATTATTCTCTGTACATGTACATGCTGTAACATATCACTCTGTAGTGACAAAAAATGGAATACTTTCAAACCTTCA 6561 TTAGTATCAAATATATATACATACACAAACATATATATGTATGTACATATATTTATTTTGTTTGTTTTTTTCCCCCGAGA 6641 CAGGGTCACTCAGGCTGGATTGCAGTGGTGTGATCTTAGCTCCCTGCAGCCTTGAACTCCTGGGCTCAAAGGATCGTCCT 6721 CCTTAGCCTCCTGAGTAGCTGGGATTACAGGCGTGTGACACCATACCTGGCTAATTTTTAAATTTTTTTTGTAGAGACAT 6801 CATCTCATTATGTTGCCCAGACTGATCTTGAACTTCTGGACTCAAGCAATCCTCCTGCCTTGGCCTCTCGAAGTGTTGTG 6881 AAGGTTAAATGAGTTAATACATAAAGTGATCTGAATGCTGCCTGACACAAAGAAAGCACTCAATAAATAGTAACTTTTA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 163590.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
CLIP-seq Support 1 for dataset GSM714645 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repB |
Location of target site | ENST00000367612.3 | 3UTR | ACUACCACACCACUCUACCACACUAUUUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
121 hsa-let-7a-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT038998 | ARMC8 | armadillo repeat containing 8 | 1 | 1 | ||||||||
MIRT038999 | SETD4 | SET domain containing 4 | 1 | 1 | ||||||||
MIRT039000 | BTF3 | basic transcription factor 3 | 1 | 1 | ||||||||
MIRT039001 | MIPOL1 | mirror-image polydactyly 1 | 1 | 1 | ||||||||
MIRT039002 | TRIM33 | tripartite motif containing 33 | 1 | 1 | ||||||||
MIRT039003 | CS | citrate synthase | 1 | 1 | ||||||||
MIRT039004 | SENP7 | SUMO1/sentrin specific peptidase 7 | 1 | 1 | ||||||||
MIRT055418 | SHOC2 | SHOC2, leucine rich repeat scaffold protein | 2 | 10 | ||||||||
MIRT057681 | LCOR | ligand dependent nuclear receptor corepressor | 2 | 8 | ||||||||
MIRT061351 | WEE1 | WEE1 G2 checkpoint kinase | 2 | 2 | ||||||||
MIRT062174 | WNK1 | WNK lysine deficient protein kinase 1 | 2 | 2 | ||||||||
MIRT071813 | RNF11 | ring finger protein 11 | 2 | 2 | ||||||||
MIRT091374 | EIF4A2 | eukaryotic translation initiation factor 4A2 | 2 | 2 | ||||||||
MIRT095107 | SEC24A | SEC24 homolog A, COPII coat complex component | 2 | 2 | ||||||||
MIRT098814 | PPIL4 | peptidylprolyl isomerase like 4 | 2 | 2 | ||||||||
MIRT109534 | KLHL15 | kelch like family member 15 | 2 | 4 | ||||||||
MIRT120263 | GSK3B | glycogen synthase kinase 3 beta | 2 | 2 | ||||||||
MIRT149839 | LDLR | low density lipoprotein receptor | 2 | 6 | ||||||||
MIRT164519 | MSMO1 | methylsterol monooxygenase 1 | 2 | 2 | ||||||||
MIRT165879 | CREBRF | CREB3 regulatory factor | 2 | 2 | ||||||||
MIRT169899 | HBP1 | HMG-box transcription factor 1 | 2 | 4 | ||||||||
MIRT182779 | TOR1AIP2 | torsin 1A interacting protein 2 | 2 | 2 | ||||||||
MIRT193466 | RORA | RAR related orphan receptor A | 2 | 2 | ||||||||
MIRT226421 | TP53INP1 | tumor protein p53 inducible nuclear protein 1 | 2 | 2 | ||||||||
MIRT334410 | CREBZF | CREB/ATF bZIP transcription factor | 2 | 6 | ||||||||
MIRT338286 | SYF2 | SYF2 pre-mRNA splicing factor | 2 | 2 | ||||||||
MIRT361627 | TES | testin LIM domain protein | 2 | 2 | ||||||||
MIRT406687 | ZNF181 | zinc finger protein 181 | 2 | 2 | ||||||||
MIRT407768 | MRPL35 | mitochondrial ribosomal protein L35 | 2 | 2 | ||||||||
MIRT449468 | HAT1 | histone acetyltransferase 1 | 2 | 2 | ||||||||
MIRT467110 | SRI | sorcin | 2 | 2 | ||||||||
MIRT475099 | IRF2BP2 | interferon regulatory factor 2 binding protein 2 | 2 | 6 | ||||||||
MIRT481671 | ARAP2 | ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 | 2 | 2 | ||||||||
MIRT493061 | MTFR1 | mitochondrial fission regulator 1 | 2 | 2 | ||||||||
MIRT497923 | BTG1 | BTG anti-proliferation factor 1 | 2 | 2 | ||||||||
MIRT498202 | ACVR2B | activin A receptor type 2B | 2 | 2 | ||||||||
MIRT503391 | ASB11 | ankyrin repeat and SOCS box containing 11 | 2 | 6 | ||||||||
MIRT503862 | UBXN2B | UBX domain protein 2B | 2 | 2 | ||||||||
MIRT504368 | ARID1B | AT-rich interaction domain 1B | 2 | 4 | ||||||||
MIRT504991 | ZNF652 | zinc finger protein 652 | 2 | 2 | ||||||||
MIRT505754 | SENP1 | SUMO1/sentrin specific peptidase 1 | 2 | 8 | ||||||||
MIRT518102 | ADH1B | alcohol dehydrogenase 1B (class I), beta polypeptide | 2 | 6 | ||||||||
MIRT521930 | PHF8 | PHD finger protein 8 | 2 | 4 | ||||||||
MIRT522139 | NRBF2 | nuclear receptor binding factor 2 | 2 | 6 | ||||||||
MIRT522401 | MYADM | myeloid associated differentiation marker | 2 | 4 | ||||||||
MIRT523593 | FZD5 | frizzled class receptor 5 | 2 | 4 | ||||||||
MIRT523944 | E2F8 | E2F transcription factor 8 | 2 | 4 | ||||||||
MIRT524355 | CREB1 | cAMP responsive element binding protein 1 | 2 | 2 | ||||||||
MIRT525140 | ZNF256 | zinc finger protein 256 | 2 | 2 | ||||||||
MIRT527070 | ABCC4 | ATP binding cassette subfamily C member 4 | 2 | 2 | ||||||||
MIRT527486 | OCIAD1 | OCIA domain containing 1 | 2 | 2 | ||||||||
MIRT528129 | PPP1R10 | protein phosphatase 1 regulatory subunit 10 | 2 | 2 | ||||||||
MIRT530528 | ALG10B | ALG10B, alpha-1,2-glucosyltransferase | 2 | 2 | ||||||||
MIRT531270 | PPIL3 | peptidylprolyl isomerase like 3 | 2 | 2 | ||||||||
MIRT538898 | BRI3BP | BRI3 binding protein | 2 | 2 | ||||||||
MIRT541371 | CDKN1B | cyclin dependent kinase inhibitor 1B | 2 | 2 | ||||||||
MIRT541526 | MGAT4C | MGAT4 family member C | 2 | 2 | ||||||||
MIRT543776 | RBM12B | RNA binding motif protein 12B | 2 | 4 | ||||||||
MIRT543946 | NCOA7 | nuclear receptor coactivator 7 | 2 | 2 | ||||||||
MIRT545156 | GABRG1 | gamma-aminobutyric acid type A receptor gamma1 subunit | 2 | 2 | ||||||||
MIRT545848 | ZNF264 | zinc finger protein 264 | 2 | 4 | ||||||||
MIRT546064 | VEZF1 | vascular endothelial zinc finger 1 | 2 | 2 | ||||||||
MIRT546481 | SLC16A14 | solute carrier family 16 member 14 | 2 | 4 | ||||||||
MIRT551835 | AASDHPPT | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | 2 | 2 | ||||||||
MIRT551901 | ACP1 | acid phosphatase 1, soluble | 2 | 2 | ||||||||
MIRT552490 | ZNF136 | zinc finger protein 136 | 2 | 2 | ||||||||
MIRT554206 | SLC35A5 | solute carrier family 35 member A5 | 2 | 2 | ||||||||
MIRT554295 | SIPA1L2 | signal induced proliferation associated 1 like 2 | 2 | 2 | ||||||||
MIRT555765 | PCTP | phosphatidylcholine transfer protein | 2 | 2 | ||||||||
MIRT558315 | DSG2 | desmoglein 2 | 2 | 2 | ||||||||
MIRT563147 | NOLC1 | nucleolar and coiled-body phosphoprotein 1 | 2 | 2 | ||||||||
MIRT566464 | PGGT1B | protein geranylgeranyltransferase type I subunit beta | 2 | 2 | ||||||||
MIRT567322 | HMGB2 | high mobility group box 2 | 2 | 2 | ||||||||
MIRT567738 | DLX2 | distal-less homeobox 2 | 2 | 2 | ||||||||
MIRT567892 | CSTF2 | cleavage stimulation factor subunit 2 | 2 | 2 | ||||||||
MIRT570087 | KANSL1L | KAT8 regulatory NSL complex subunit 1 like | 2 | 2 | ||||||||
MIRT571136 | TTC33 | tetratricopeptide repeat domain 33 | 2 | 2 | ||||||||
MIRT573534 | MDM2 | MDM2 proto-oncogene | 2 | 2 | ||||||||
MIRT574465 | RPS16 | ribosomal protein S16 | 2 | 2 | ||||||||
MIRT574998 | Phka1 | phosphorylase kinase alpha 1 | 2 | 3 | ||||||||
MIRT610202 | CD99 | CD99 molecule (Xg blood group) | 2 | 4 | ||||||||
MIRT612926 | GPRIN3 | GPRIN family member 3 | 2 | 2 | ||||||||
MIRT615027 | DUSP6 | dual specificity phosphatase 6 | 2 | 2 | ||||||||
MIRT617200 | GREM1 | gremlin 1, DAN family BMP antagonist | 2 | 2 | ||||||||
MIRT628720 | ZNF585A | zinc finger protein 585A | 2 | 2 | ||||||||
MIRT641491 | POLA2 | DNA polymerase alpha 2, accessory subunit | 2 | 2 | ||||||||
MIRT641663 | PAPOLG | poly(A) polymerase gamma | 2 | 2 | ||||||||
MIRT642216 | RUVBL2 | RuvB like AAA ATPase 2 | 2 | 2 | ||||||||
MIRT654589 | PURA | purine rich element binding protein A | 2 | 2 | ||||||||
MIRT656136 | MSH6 | mutS homolog 6 | 2 | 2 | ||||||||
MIRT656899 | KIAA2018 | upstream transcription factor family member 3 | 2 | 2 | ||||||||
MIRT660136 | BRPF3 | bromodomain and PHD finger containing 3 | 2 | 2 | ||||||||
MIRT660861 | AFAP1 | actin filament associated protein 1 | 2 | 2 | ||||||||
MIRT676849 | PHKA1 | phosphorylase kinase regulatory subunit alpha 1 | 2 | 3 | ||||||||
MIRT681479 | DIP2A | disco interacting protein 2 homolog A | 2 | 2 | ||||||||
MIRT682259 | RS1 | retinoschisin 1 | 2 | 2 | ||||||||
MIRT685602 | MYOM2 | myomesin 2 | 2 | 2 | ||||||||
MIRT686943 | SFT2D3 | SFT2 domain containing 3 | 2 | 2 | ||||||||
MIRT694302 | COPB2 | coatomer protein complex subunit beta 2 | 2 | 2 | ||||||||
MIRT694407 | ALDH1A3 | aldehyde dehydrogenase 1 family member A3 | 2 | 2 | ||||||||
MIRT697280 | ZNF800 | zinc finger protein 800 | 2 | 2 | ||||||||
MIRT698414 | TM4SF1 | transmembrane 4 L six family member 1 | 2 | 2 | ||||||||
MIRT698989 | SPAG9 | sperm associated antigen 9 | 2 | 2 | ||||||||
MIRT699766 | SEMA4D | semaphorin 4D | 2 | 2 | ||||||||
MIRT699928 | RUFY2 | RUN and FYVE domain containing 2 | 2 | 2 | ||||||||
MIRT702113 | MBNL1 | muscleblind like splicing regulator 1 | 2 | 2 | ||||||||
MIRT702373 | KLF10 | Kruppel like factor 10 | 2 | 2 | ||||||||
MIRT702646 | ITGA3 | integrin subunit alpha 3 | 2 | 2 | ||||||||
MIRT705713 | ANAPC16 | anaphase promoting complex subunit 16 | 2 | 2 | ||||||||
MIRT717925 | ZNF546 | zinc finger protein 546 | 2 | 2 | ||||||||
MIRT720839 | C1orf52 | chromosome 1 open reading frame 52 | 2 | 2 | ||||||||
MIRT725033 | NDUFAF7 | NADH:ubiquinone oxidoreductase complex assembly factor 7 | 2 | 2 | ||||||||
MIRT731448 | APOBEC3A | apolipoprotein B mRNA editing enzyme catalytic subunit 3A | 1 | 1 | ||||||||
MIRT733217 | CCNG1 | cyclin G1 | 2 | 0 | ||||||||
MIRT734887 | LIN28B | lin-28 homolog B | 1 | 0 | ||||||||
MIRT735276 | HMGA2 | high mobility group AT-hook 2 | 2 | 0 | ||||||||
MIRT735727 | SYNCRIP | synaptotagmin binding cytoplasmic RNA interacting protein | 3 | 0 | ||||||||
MIRT736087 | RCVRN | recoverin | 1 | 0 | ||||||||
MIRT736088 | RHO | rhodopsin | 1 | 0 | ||||||||
MIRT736103 | TLR7 | toll like receptor 7 | 1 | 0 | ||||||||
MIRT736607 | TPO | thyroid peroxidase | 2 | 0 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|